Xiaohui Chang

Title: Innovations by Xiaohui Chang in Pharmaceutical Development

Introduction

Xiaohui Chang is a notable inventor based in Jilin, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable drug formulations. His work is characterized by a focus on improving the stability and efficacy of injectable medications.

Latest Patents

Xiaohui Chang holds a patent for a "Stable secukinumab injection and preparation method therefor." This innovative formulation includes 50 mg/ml-300 mg/ml of secukinumab, along with histidine, methionine, a low-sugar alcohol, and polysorbate 80, with water for injection as the balance. The pH of the solution is maintained between 5.0-7.0. Stability tests have demonstrated that this formulation is superior to existing commercial varieties, meeting the relevant regulations of the Chinese Pharmacopoeia and showing promising application prospects.

Career Highlights

Xiaohui Chang is currently employed at Tonghua Dongbao Pharmaceutical Co., Ltd. His work at this company has allowed him to focus on innovative drug development, contributing to advancements in pharmaceutical technology. His dedication to research and development has positioned him as a key figure in the industry.

Collaborations

Xiaohui has collaborated with colleagues such as Xindan Fan and Depeng Wang. These partnerships have fostered a collaborative environment that enhances the innovation process within the company.

Conclusion

Xiaohui Chang's contributions to pharmaceutical innovations, particularly through his patent for a stable secukinumab injection, highlight his role as a significant inventor in the field. His work not only advances drug stability but also promises to improve patient outcomes in therapeutic applications.